Zoo Capital et al to Advance Immunotherapy Solutions
25 Apr 2025
US$ 20.00
Zoo Capital has led in the US$40 m series A+ financing round of LTZ Therapeutics Inc (LTZ), joined by Lanchi ......
Related Publications
Subscribers’ Weekly...
Listen to Australia/New Zealand Investments (Subscribers' Weekly 02 May 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.